Publications

February 22, 2024

Tandem Meetings – 2024 – Encore Poster Presentation 293

VCAR33 (Allogeneic)

Phase 1/2 Study of Donor-Derived Anti-CD33 Chimeric Antigen Receptor Expressing T Cells (VCAR33ALLO) in Patients with Relapsed or Refractory Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation (Trial in Progress)